Last updated on October 2018

A phase 3 study of A-101 topical solution applied twice a week in subjects, 2 years and older, with common warts.


Brief description of study

The purpose of this research study is to test the safety and effectiveness of a new investigational drug, A-101 45% Topical Solution, that is applied only to the skin. An “investigational drug” is a drug that is being tested and is not approved for use in the United States by the U.S. Food and Drug Administration (FDA).  In addition, this study will compare A-101 45% Topical Solution with a placebo to see if using A-101 45% Topical Solution is better than using a placebo. The placebo is a solution that looks like A-101 45% Topical Solution but has no drug in it.

If you decide to be in this study and the study doctor says you can be in the study, your participation will last about 5 months and includes 13 visits to the study center.  If you decide to be in this study, you will first enter the study’s screening period, which may last up to 13 days.  If you continue your participation after the screening period, you will begin the study drug application period.

 

Clinical Study Identifier: TX213555

Find a site near you

Start Over

Center for Clinical Studies, LTD. LLP.

451 N. Texas Avenue Webster, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.